CAINFECTOME

Unravelling the infectome of Candida albicans

 Coordinatore LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS KNOELL INSTITUTE 

 Organization address address: Beutenbergstrasse 11a
city: JENA
postcode: 7745

contact info
Titolo: Prof.
Nome: Bernhard
Cognome: Hube
Email: send email
Telefono: +49 36 41 65 68 80
Fax: +49 36 41 65 68 82

 Nazionalità Coordinatore Germany [DE]
 Totale costo 166˙982 €
 EC contributo 166˙982 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2007-2-1-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-06-01   -   2010-05-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS KNOELL INSTITUTE

 Organization address address: Beutenbergstrasse 11a
city: JENA
postcode: 7745

contact info
Titolo: Prof.
Nome: Bernhard
Cognome: Hube
Email: send email
Telefono: +49 36 41 65 68 80
Fax: +49 36 41 65 68 82

DE (JENA) coordinator 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

oral    host    problem    scientists    niche    ability    gene    mechanisms    blood    unknown    genes    candida    expressed    elucidate    models    disease    changing    causes    alters    immune    albicans    function    serious    deletion    human    fungus    transcriptional    medical    expression    mutants    impaired    anatomical    infection    then    interaction    cainfectome    liver    successfully   

 Obiettivo del progetto (Objective)

'The opportunistic human fungal pathogen, Candida albicans causes a wide range of serious disease manifestations, especially in individuals with an impaired immune system. The ability of C. albicans to successfully infect almost every anatomical niche of the human host is both a serious medical problem and an interesting biological property. It is known from in vitro transcriptional profiling that the organism rapidly alters gene expression in response to changing environments; however, very little is known of gene expression patterns in vivo. In addition, a significant proportion of C. albicans genes expressed during infection have no known function. This study will address these two problems in the following ways. Firstly, the transcriptional profile of C. albicans interaction with the host during three distinct models of infection (oral, liver and blood) will be analysed to determine whether C. albicans responds using general transcriptional mechanisms during infection or whether responses are specific depending on the anatomical niche. This transcriptional analysis will then form the basis of a systematic disruption strategy to elucidate the function and role of unknown function genes. Relevant deletion mutants will be generated using a rapid PCR based method and tested for host-interaction using established models of infection. This characterisation will elucidate the function of unknown function genes during infection and describe de novo properties of C. albicans biology. Furthermore, by testing mutants in more than one model of infection it will be shown whether a gene upregulated specifically during one type of infection has significance in another.'

Introduzione (Teaser)

Patients with impaired immune systems can be vulnerable to serious infection from the fungus Candida albicans. An EU-funded project has investigated how the infection is caused and how it can be treated.

Descrizione progetto (Article)

Infection depends upon a number of factors, although exactly how the fungus causes disease has not been clearly understood, until now. One of the main factors behind C. albicans virulence is its ability to grow both as ovoid yeast cells and as long, branching filamentous structures called hyphae.

The 'Unravelling the infectome of Candida albicans' (Cainfectome) project has identified new molecular mechanisms that can contribute to the microorganism's ability to cause infection. Research has involved the analysis of models of oral, liver and blood infection. The models have successfully identified aspects of gene expression during infection.

Project partners selected a set of 40 previously uncharacterised genes involved in infection and removed genes of interest through targeted deletion. The result has been the creation of a set of infection-associated gene deletion mutants. The mutant set was then screened for the potential ability to cause disease in two infection models.

Data from the Cainfectome project will help scientists understand how C. albicans rapidly alters the way its genes are expressed in response to a changing environment. In so doing, the initiative will enable EU scientists to provide an answer to this serious medical problem.

Altri progetti dello stesso programma (FP7-PEOPLE)

ECONAT (2010)

Economic Nationalism and the European Union: The case of the automobile industry

Read More  

3DSSS (2009)

New catalytic strategies for chemical synthesis: Enantioselective Organocatalytic Dearomatization – From flat molecules to complex 3-D architectures in a single step

Read More  

TRNOILOS (2012)

The role of nitric oxide in survival of low oxygen stress in plants

Read More